We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+3.67%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$22.8B
AUM Growth
-$4.8M
Cap. Flow
+$69.6M
Cap. Flow %
0.31%
Top 10 Hldgs %
39.53%
Holding
188
New
24
Increased
37
Reduced
34
Closed
37

Top Sells

Rank Stock Value
1
CTLT
CATALENT, INC.
CTLT
+$508M
2
CRM icon
Salesforce
CRM
+$266M
3
NOW icon
ServiceNow
NOW
+$264M
4
SPGI icon
S&P Global
SPGI
+$246M
5
SHW icon
Sherwin-Williams
SHW
+$212M

Sector Composition

Rank Sector Weight
1 Healthcare 33.98%
2 Technology 14.71%
3 Financials 12.17%
4 Communication Services 7.05%
5 Industrials 4.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRFS
126
Grifois
GRFS
$5.4B
$208K ﹤0.01%
28,000
INSM icon
127
Insmed
INSM
$28.6B
$207K ﹤0.01%
3,000
ONC
128
BeOne Medicines Ltd
ONC
$39.4B
$203K ﹤0.01%
1,100
ALT icon
129
Altimmune
ALT
$599M
$199K ﹤0.01%
27,600
ELAN icon
130
Elanco Animal Health
ELAN
$11.1B
$194K ﹤0.01%
16,000
IOVA icon
131
Iovance Biotherapeutics
IOVA
$2.87B
$192K ﹤0.01%
26,000
SLDPW icon
132
Solid Power Inc Warrant
SLDPW
$10.6M
$182K ﹤0.01%
405,316
EVH icon
133
Evolent Health
EVH
$447M
$158K ﹤0.01%
14,000
-625,000
-98% -$11M
GERN icon
134
Geron
GERN
$949M
$152K ﹤0.01%
43,000
FOLD
135
DELISTED
Amicus Therapeutics
FOLD
$151K ﹤0.01%
16,000
OSCR icon
136
Oscar Health
OSCR
$8.61B
$148K ﹤0.01%
11,000
ANNAW
137
AleAnna Inc Warrant
ANNAW
$8.06M
$139K ﹤0.01%
+990,000
New +$151K
COGT icon
138
Cogent Biosciences
COGT
$7.24B
$133K ﹤0.01%
17,000
SNDX icon
139
Syndax Pharmaceuticals
SNDX
$1.82B
$132K ﹤0.01%
10,000
NVAX icon
140
Novavax
NVAX
$1.31B
$129K ﹤0.01%
16,000
ARDX icon
141
Ardelyx
ARDX
$997M
$117K ﹤0.01%
23,000
CCCC icon
142
C4 Therapeutics
CCCC
$412M
$101K ﹤0.01%
28,000
CGC
143
Canopy Growth
CGC
$410M
$82.2K ﹤0.01%
30,000
IRWD icon
144
Ironwood Pharmaceuticals
IRWD
$714M
$57.6K ﹤0.01%
13,000
ANNA
145
AleAnna Inc
ANNA
$105M
$48.7K ﹤0.01%
+78,400
New +$569K
GATEW
146
DELISTED
Marblegate Acquisition Corp. Warrant
GATEW
$48.3K ﹤0.01%
1,485,000
CITEW
147
DELISTED
Cartica Acquisition Corp Warrant
CITEW
$47.3K ﹤0.01%
175,000
NVNIW
148
Nvni Group Limited Warrants
NVNIW
$836K
$24.8K ﹤0.01%
375,000
RVMDW icon
149
Revolution Medicines Inc Warrant
RVMDW
$127M
$19.4K ﹤0.01%
120,085
AMGN icon
150
Amgen
AMGN
$222B
-47,000
Closed -$15.1M

Similar funds

Farallon Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Farallon Capital Management held 188 positions worth $22.8B, down 0.02% from $22.8B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Farallon Capital Management's Q4 2024 filing shows 24 new, 37 increased, 34 reduced and 37 closed positions. Its largest new stake was Autodesk: 1,841,800 shares worth $544M. The largest sale was CATALENT, INC., an estimated $508M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Farallon Capital Management's largest Q4 2024 buy was Autodesk: 1,841,800 shares worth $544M.
  • Farallon Capital Management added most to Discover Financial Services in Q4 2024, an estimated $580M increase.
  • Farallon Capital Management's biggest Q4 2024 reduction was Salesforce, cutting an estimated $266M.
  • Farallon Capital Management fully exited CATALENT, INC. in Q4 2024, selling an estimated $508M.
  • Farallon Capital Management's ten largest holdings make up 40% of its $22.8B portfolio in Q4 2024.
  • Farallon Capital Management opened 24 new positions and closed 37 in Q4 2024.
  • Farallon Capital Management's portfolio value fell 0.02% quarter-over-quarter to $22.8B.

Based on Farallon Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.